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Abstract
: Primary cell culture using serum free media supplementedBackground
with growth factors has been used in a number of cancers to propagate
primary cells with stem like properties, which form as spherical cellular
aggregates.
: We systematically evaluated the capacity of freshlyMethods
disaggregated neuroblastoma tumors to become established as
neurospheres in stem cell media using a uniform protocol. 67 primary
neuroblastoma samples from patients treated at a single institution were
prospectively evaluated for their ability to become established in culture.
Samples, either solid tissue or cells from surgical transit fluid both post
chemotherapy and chemotherapy naïve, were evaluated from diagnostic
needle biopsies or surgical resections.
: Overall 37 neurosphere cultures were successfully establishedResults
from 67 samples. In 11 out of 14 cases investigated by flow cytometry,
uniform staining for neuroblastoma markers CD56 and GD2 was
demonstrated in CD45 negative non-hemopoietic cells, confirming
neuroblastoma origin.
: We present a simple and reproducible approach forConclusion
producing primary neurospheres from neuroblastoma samples, which
provides a reliable resource for future work including genetic analysis, stem
cell research and models for therapeutics.
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Abbreviation Full term
NBL Neuroblastoma
SCM Stem Cell Media
CNS Central Nervous System
EGF Epidermal Growth Factor
FGF Fibroblast Growth Factor
Background
Neuroblastoma is the most common extra-cranial solid tumor 
occurring in children, and the most commonly diagnosed 
cancer in children under the age of 1 year1. Tumors are thought 
to have embryological origin in the neural crest, arise within 
the sympathetic chain or adrenal gland, and are frequently 
metastatic2. The disease is strikingly heterogeneous with a range 
of clinical phenotypes, from spontaneous regression, includ-
ing in cases with metastases, to aggressive disease with marked 
resistance to radiotherapy and chemotherapy. New approaches 
to therapies supported by the availability of suitable tumor 
models that more closely resemble the human disease are 
essential for improving outcomes for this disease.
Established neuroblastoma cell lines have the advantage of being 
widely available, and enable comparison of research worldwide 
by their use as a common standard. However, cell lines are lim-
ited in their ability to reflect disease physiology due to adap-
tation to prolonged culturing conditions. Inevitable evolution 
and changes in transcriptional response occur during culturing, 
which vary between laboratories3,4, and may alter diverse cell 
behaviors such as drug response. The potential for proliferation 
of subclones with greater intrinsic capacity to survive in vitro 
may lead to loss of genetic variability within a cell line compared 
with polyclonal cancer populations in humans.
Increasingly it is recognized that in vivo mouse models of tumors, 
established in immunodeficient animals following minimal or no 
in vitro passaging (Patient-Derived Xenografts; PDX) is a valu-
able tool for evaluation of therapeutic agents. Whilst many PDX 
models have been established by immediate surgical implan-
tation of freshly acquired tumor surgical samples, this is not 
always a practical approach. Neurospheres are spherical cellu-
lar clusters derived from neural stem cells, that develop under 
culture conditions of serum free media supplemented with growth 
factors5. Initially produced from adult CNS tissue, they were the 
first demonstration of proliferative capacity in the adult brain, 
and have since been derived from embryonic stem cells, and 
CNS tumor cells. Cancer stem cells have been identified in a 
range of malignancies6, and have been implicated in initiation 
and progression of solid tumors7, and development of resistance 
to therapy. Growth of neurospheres in stem cell media is 
hypothesized to enrich for cancer stem cells. Given the impor-
tance of cancer stem cells as a potential target for treatment 
options, and the advantages of primary cultures over standard 
cell lines, it is necessary to clarify and validate methods for 
culturing neurospheres from primary material in neuroblastoma.
It is therefore important to investigate avenues of utilizing shorter 
term primary cultures such as those established in stem cell 
media, based on the hypothesis that they may still remain rep-
resentative of the driver genetic features of the original tumor 
stem cells, and have limited adaptive changes to tissue culturing 
conditions. Hence, we sought to establish neurosphere primary 
lines from neuroblastoma surgical samples, to determine the 
reproducibility of the technique, and to generate a resource 
for future research studies in therapeutics, genetics and stem 
cell biology. We found a high overall success rate (55%) of 
establishment from surgical samples.
Methods
Patients and consent
The study had ethical review board approval (REC refer-
ence 14/WM/1253 “Establishing primary cultures and cell 
lines from pediatric cancers”) and samples were made avail-
able following informed consent. Patients were eligible if there 
was a known or suspected diagnosis of neuroblastoma. All 
samples were included based on known or suspected diagno-
sis of neuroblastoma without selection on clinical criteria. In 
some cases with insufficient material for culture, the transport 
fluid used for sample transfer (0.9% saline) was placed directly 
into culture.
Tumor preparation
Tru-cut needle biopsies or tissue from tumor resections from 
neuroblastoma patients were transferred directly from operat-
ing theatre to the hospital histopathology laboratory. Following 
sterile cut up and routine diagnostic processing including freez-
ing of material for research, surplus material was evaluated by 
a consultant pathologist for tissue viability and made available 
for culture. Tissue was manually disaggregated in a 10cm tissue 
culture dish using a sterile scalpel. Tumors that dissociated read-
ily in this way were placed immediately into stem cell media in 
25cm2 flasks, 24 well plates or 12 well plates depending on the 
available tissue. Since it is not possible to perform an accurate 
cell count on the partially dissociated tumor, choice of culture 
container was based on estimation of size that would yield 
approximately 100% confluence, were the sample fully disag-
gregated. Where spare solid material was unavailable from a 
biopsy, up to 1ml of saline used to transport the sample to the 
histopathology laboratory was taken and added to 4ml of stem 
cell media in a 25cm2 flask. When more than 1ml of transit 
fluid was provided, it was centrifuged at 300G for 5 minutes 
and the pellet resuspended in stem cell media. Samples that 
were tougher to disaggregate were digested with Accutase 
(Thermofisher 00-4555-56) for up to 1 hour, or until obvious 
disaggregation was observed, and divided between wells of a 
multiwell plate based on the estimation of confluence as above.
Culture conditions
Disaggregated cells and tumor fragments were placed into 
standard serum free neurosphere culture media (Stem Cell 
Media, SCM) composed of DMEM/F12 (Sigma-Aldrich 
D8437),° 1% B27 (Gibco 17504044) with 20ng/ml EGF (Sigma 
Aldrich #E9644) and 20ng/ml FGF (Fibroblast Growth Factor, 
Peprotech 100 – 18B) in the presence of penicillin and streptomy-
cin antibiotics. Cells were propagated at 37°C in 5% CO2. Cul-
tures were inspected twice a week for cell density and presence 
of neurospheres, and split 1:2 to 1:5 depending on cell density and 
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speed of growth. Cultures were frozen in serum free DMEM/F12 
media with 10% DMSO at approximately 107 cells per ml.
Neurosphere disaggregation and flow cytometry
A total of 14 randomly selected representative primary cultures 
were analyzed by flow cytometry. To produce a single cell sus-
pension necessary for this, cells growing as a monolayer were 
detached with Accutase (Thermofisher) according to the manu-
facturer’s instruction, while neurospheres were disaggregated 
with Accutase and the mechanical force of gentle pipetting. 
Surviving cells, re-suspended into single cell suspension, were 
stained in FACS tubes using saturating amounts (1–5ul of 
stock) of antibody in 100ul PBS using the following panel of 
directly conjugated monoclonal antibodies all from Biolegend: 
GD2-PE (357304, RRID: AB_2561885), CD56-APC/Cy7 
(318332, RRID: AB_10896424), CD45-BV711 (304049, RRID: 
AB_2563465) controlled for nonspecific staining using isotype- 
matched labelled polyclonal antibodies. The stained primary 
culture cells were incubated on ice with antibody mix for 
30 minutes and then washed with PBS and centrifuged at 300G 
for 5 minutes. Data was collected with the BD LSRII flow 
cytometer (BD Biosciences) and data analysis used FlowJo 
software (v8.8.3).
The gating strategy excluded dead cells by a live/dead stain 
using DAPI. To exclude leukocytes that may be present from 
blood in the original sample, the resulting live population was 
gated on CD45 negative and CD56 positive cells, the latter a 
standard marker for neuroblastoma. This gated cell population 
of CD45-ve/CD56+ve cells was then examined for expression 
of GD2, also ubiquitously expressed on neuroblastoma.
Statistical analysis
Chi-squared tests were used to determine significance of asso-
ciation of categorical variables; for example successful versus 
non successful expansion correlated with pre versus post chem-
otherapy. Data were tabulated and tests of significance were 
performed using Microsoft Excel 2016 and GraphPad Prism v6.0
Results
Neurosphere cultures can be established from the majority 
of neuroblastoma patient samples grown in suspension 
cultures and retain typical neuroblastoma surface 
immunophenotype
Between October 2014 to end of 2016, tumor biopsies or resec-
tions of 67 consecutive neuroblastoma samples from 52 patients 
treated at Great Ormond Street Hospital London were system-
atically evaluated for their ability to establish primary neuro-
sphere lines. Of these, 39 were primary needle biopsies and 28 
were surgical resections of which 24 were post chemotherapy 
resections and 4 were primary (treatment-naïve) resections.
The success in terms of establishment of cultures was deter-
mined by the ability of cultures to produce discrete visible 
neurospheres. All cultures derived from neuroblastoma samples 
were observed to grow as a mixture of phenotypes including 
neurospheres, single suspension cells, and as monolayer, 
although often one of the three growth patterns was predomi-
nant. Cases could be dichotomized into those that formed 
spheres within the first 14 days of establishment and then went 
on to form long term successful cultures, and those that never 
formed spheres and were classified as “unsuccessful cultures”. 
The overall success rate, as thus defined, was 55%. It appeared 
that successful establishment of neurospheres could be made 
from chemotherapy-naïve primary tumors and post chemother-
apy surgical samples, as well as primary needle biopsies. Suc-
cessful establishment of lines is summarized in Table 1. Of 43 
chemotherapy-naive samples (39 biopsies and 4 surgical exci-
sions), 29 (67%) were successfully established, whereas for 
the post-chemotherapy surgical samples success rate was 8 out 
of 24 (33%), which is significantly inferior (Chi Sq p=<0.008) 
(see underlying data8). This suggests that the protocol, if 
applied to optimally procured tissue, would have a success rate 
over 65%.
Due to the impossibility of counting cells both at the start of 
culturing and following establishment of spheres, it is not possi-
ble to plot growth curves. However, the range of time from initial 
seeding to establishment of a confluent 75cm2 flask is approxi-
mately 2 to 10 weeks showing the marked heterogeneity of 
growth rates.
In order to determine that these were neuroblastoma cells, 14 
representative samples were analyzed by flow cytometry. Cells 
from primary cultures were assessed for expression of the pan 
leucocyte marker CD45, which neuroblastoma cells do not 
express, and for ubiquitously expressed NBL markers CD56 and 
GD2. Of the samples tested, 79% exhibited this characteristic 
neuroblastoma staining pattern. We found that the neurosphere 
cultures showed a very bright and homogeneous staining for 
both NBL markers (Figure 1)
Neurosphere cultures can be successfully established 
from transit fluid samples and retain typical neuroblastoma 
immunophenotype
We were interested in whether it is possible to establish neurob-
lastoma lines when using very small amounts of tissue. In cases 
with insufficient tissue to culture, 1ml of transportation fluid 
was put directly into 4ml stem cell media (SCM) in a 25cm2 
Table 1. Establishment of sphere cultures from primary 
sample type. Of the chemotherapy-naïve surgical excisions, 
2 of these 4 were from recurrences.
Samples Sphere cultures (%)
Total samples 67 37 (55)
Total fluid only samples 17 9 (53)
Total solid samples 50 28 (56) 
Total biopsy samples 39 25 (64)
Diagnostic biopsies 34 21 (62)
Recurrence biopsies 5 4 (80)
Biopsy fluid only cultures 15 9 (60)
Total excision samples 28 12 (43)
Post chemotherapy 24 8 (33)
Chemotherapy naive 4 4 (100)
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tissue culture flask, testing the hypothesis that small amounts of 
residual tumor cells within the transport media would be able 
to establish. Where transport fluid provided was more than 
1ml, this was centrifuged and the pellet resuspended in SCM. 
Cultures established from transit fluid had a comparable success 
rate to those established from solid tissue samples (9 out of 
15= 55% versus 25 out of 39 =64% for biopsies: Chi Sq p=0.78).
To perform a further unbiased comparison, eight patients had 
neurospheres cultured from the same biopsy with separate cul-
turing of the solid tissue and surgical transit fluid. In three there 
was no successful growth, in three there was concordance of 
growth from the two sources, and in two there was success from 
solid tissue but not transit fluid; there were no cases with 
success of transit fluid but failure from solid tissue. Therefore 
transit fluid appears a less reliable source of material but a 
useful adjunct in the context of scarce material.
Heterogeneity of in vitro growth phenotype and adaptation 
to growth on laminin
In addition to growth as neurospheres, primary cultures estab-
lished in SCM were observed to grow as adherent monolay-
ers, single cell suspensions, or mixtures of all three growth 
patterns. Moreover, there is marked heterogeneity in the size 
of neuropheres both within and between samples. It is not 
possible to quantify this heterogeneity, but all the NBL SCM 
lines contained some elements of adherent, single cell suspen-
sion and neurospheres. SCM derived from gliomas can be grown 
as adherent cultures by coating culture flasks with laminin and 
so we were interested in whether neuroblastoma primary cultures 
could also adopt this phenotype. We did not attempt initial 
establishment in laminin in any cases. In our hands, when estab-
lished or establishing SCM lines were transferred to laminin, 
the degree of attachment increased markedly, with outgrowth of 
adherent spheres and associated adherent cells growing out as a 
Figure 1. Neurospheres derived from neuroblastoma primary tumors retain typical immunophenotype. A) representative flow 
cytometric staining for two independent cultures (excision culture 3544 (upper) and biopsy culture 4669 (lower) following gating on live cells. 
B) graphical representation of the staining pattern in 14 evaluated samples; positivity was categorized into dim, medium and bright based 
on MFI and scored as 1, 2 and 3 respectively.
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monolayer. In some cases where growth in suspension appeared 
slow, the change to laminin appeared to accelerate growth. 
Because of the impossibility of counting cells in neuropheres 
without majorly disrupting them, it was not possibly to quantify 
these aspects of altered growth in laminin. On return of laminin 
cultured cells to non-coated flasks, they reverted to predominant 
suspension growth pattern.
No significant association between success rate with 
clinical/histological features
Patient characteristics and ability to establish neurospheres is 
shown in Table 2. The number of male samples were 37 out of 
67. The ability to establish neurospheres did not vary depend-
ing on gender (59% vs 50%). Biopsies which demonstrated only 
undifferentiated neuroblastoma had a higher but non-significant 
success rate in establishing neurospheres than those which 
showed any evidence of differentiation or post chemotherapy 
changes (60% vs 45%). Age, stage, MYCN amplification and 
the presence of segmental chromosomal aberrations were all 
non significant in terms of neurosphere success rate (Table 2). 
Six patients had two samples collected at different time points 
during treatment. For four of them there was no concordance 
for success between the timepoints whereas two patients 
(one success and one failure) the different timepoints were 
concordant. Therefore we failed to find any evidence that patient- 
specific factors govern success rate. 
Discussion
Here we present data from a series of 67 samples diagnosed 
with neuroblastoma, from which tumor tissue or surgical tran-
sit fluid was obtained and used to culture tumor spheres under 
conditions commonly used in the culture of neural stem cells6. 
Tumor spheres were subsequently dissociated and assessed by 
flow cytometry for presence of neuroblastoma markers GD2 and 
CD56, to show that cells and tumor spheres grown in culture 
retain the characteristic markers the cells of their tissue of ori-
gin. These cells may then be used as targets in vitro for drug 
development, or for engraftment in vivo for the develop-
ment of patient-derived xenograft models that better reflect the 
heterogeneity of this disease.
Although well established that it is possible to use SCM 
to propagate stem cells in the form of neurospheres from a 
number of different cancer types9, the literature is sparse in 
regards to their evaluation in neuroblastoma. We have therefore 
systematically evaluated success rate and shown that with 
simple culturing techniques it is possible to establish primary 
lines which retain the characteristic immunophenotypic features 
of neuroblastic tumors. Further studies will be required to estab-
lish the success rate of formation of tumors, for example in 
xenograft models. Moreover, it will be interesting to study the 
ability of these cells to differentiate into neuroblasts in vitro, for 
example by transfer to normal growth media with serum, as well 
as the mutational drift compared to the original tumor if any.
It would be advantageous to have a method of establishment 
of primary cell culture which reproducibly leads to cell expan-
sion. Even if the expanded cells represent a subclone that are 
adapted to in vitro conditions (for example cancer stem cell 
expansion in stem cell media), this still represents an advan-
tage over methods such as establishment of cell lines in normal 
growth media with serum, that typically go through a crisis phase 
before establishment of an emergent line that is presumably 
highly evolved for adaptation to tissue culture conditions, and 
therefore less likely to represent the in vivo tumor. Conven-
tional two-dimensional monolayer models have been useful 
in understanding many of the characteristics of neuroblastoma 
cell biology, but in addition to the concerns about genetic 
evolution to adapt to typical cell culture conditions, they do 
not accurately reflect the multicellular physiology of tumors 
in vivo or how the tumor microenvironment is developed. 
Neither adherent monolayer cultures nor neurospheres are physi-
ological, and occur only during in vitro culturing conditions, 
however the latter may offer some advantages as a research tool. 
Although neurospheres do not have the architecture and vas-
culature of in vivo tumors, their three-dimensional structure 
may have advantages of cell monolayers in terms of better rep-
resenting aspects of three-dimensional tumors such as central 
hypoxia and drug penetrance. Future studies on neurosphere 
permeability and response to therapeutics might be of interest 
to evaluate their role as an in vitro tumor model.
Table 2. Patient features and correlation with 
establishment of spheres. There were no significant 
associations with neurosphere establishment (Chi-square). 
L1, L2, M or MS stage disease at diagnosis used the 
International Neuroblastoma Risk Group (INRG) Classification 
System.
Number (%) Successful Establishment 
of spheres (%)
Gender
Male 37 (55) 22 (59)
Female 30 (45) 15 (50)
Age
<=18months 36 (54) 23 (64)
>18months 31 (46) 14 (45)
INRG Stage at Diagnosis
L1 3 (4) 2 (67)
L2 21 (31) 14 (67)
M 39 (58) 18 (46)
MS 4 (6) 3 (75)
NMYC Amplification
Yes 17 (25) 7 (41)
No 50 (75) 30 (60)
Segmental Chromosomal Abnormalities
Yes 21 (31) 14 (67)
No 46 (69) 23 (50)
Tumor Biology
Undifferentiated 47 (70) 28 (60)
Differentiating 20 (30) 9 (45)
Page 6 of 13
F1000Research 2019, 8:823 Last updated: 08 JUL 2019
The establishment of neurospheres comprised of primary neu-
ral stem cells has also been frequently used and there exist a 
variety of methods for their establishment6. However, the sphere 
culture model is limited by its sensitivity to culture technique 
including sensitivity to alterations in media or cell density, or 
frequent passaging and dissociation5,10. In our hands the neu-
roblastoma SCM cultures do show this sensitivity to changes in 
environmental conditions but retain the capacity to recover 
from stress if left alone in normal SCM growth conditions. Due 
to the long-term nature of their propagation, meticulous atten-
tion to sterility is needed to prevent the outbreak of microbial 
contamination. 
While neurospheres represent a straightforward approach for 
maintaining cancer cells in culture, and whilst they are a poten-
tially useful tool for cancer stem cell investigations, further 
studies are needed to determine how useful they will be in 
developing biological or therapeutics models for basic or trans-
lational research. Our demonstration of high success rate of 
their establishment using a uniformly applied protocol is a 
valuable contribution to the field for identifying an alternate and 
reproducible approach to expanding the reagents available for 
neuroblastoma research.
Ethics approval and consent to participate
The study had ethical review board approval (REC reference 
14/WM/1253 “Establishing primary cultures and cell lines 
from pediatric cancers”) and all patient samples were collected 
with written full consent
Data availability
Underlying data
Open Science Framework: Primary neuroblastoma cultures 
database. https://doi.org/10.17605/OSF.IO/T2RFB8
This project contains the following underlying data:
•    FACS data (folder containing output FACS files for 
different cases)
•    Flow Cases - reference table.docx (Reference table for 
FACS output files)
•    Full data sheet no identifiers.xlsx (spreadsheet of sample 
characteristics)
Data are available under the terms of the Creative Commons 
Attribution 4.0 International license (CC-BY 4.0).
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Neuroblastoma is a clinically and genetically heterogeneous pediatric tumor. Precise biological and
molecular characterization of tumor cells is increasingly becoming an integral part of patient care, with
treatment stratification depending not only on clinical, but also on molecular characteristics. However,
tumor samples are frequently small, especially when obtained by fine needle biopsies, with frequently
only a limited amount of biological material available for increasingly complex molecular investigations or
cellular screening procedures.
In this manuscript, the authors describe the technical aspects of direct culture of neuroblastoma samples
for the establishment of neurosphere cultures. Importantly, they describe a procedure which is applied to
consecutive cases in a single center, with samples obtained by different techniques (surgical resections,
fine needle biopsies, transport fluid) and at different time points (at diagnosis, post chemotherapy). The
success rate is 55% (37/67 samples), without any significant association between the success rate of
establishing a neurosphere culture and clinical/histological/genetic features. Characterization of the
obtained neurosphere cultures is still limited, but the results indicate that the cultured cells do express
neuroblastoma markers.
The ultimate usefulness of the established neurosphere cultures will depend on a number of aspects. It
will be necessary to compare genetic/epigenetic/cell identity features between the primary tumor and
corresponding neurosphere culture, to search more in detail for features linked to culture success rates
and to establish the duration of tumor growth.
The importance of this work is linked to the presentation of a reproducible method for the expansion of
frequently rare tumor tissue, enabling more large scale use of such samples for molecular
characterization, drug screening and other applications for the patients’ benefit.
Is the work clearly and accurately presented and does it cite the current literature?
Yes
Is the study design appropriate and is the work technically sound?
Yes
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 Yes
Are sufficient details of methods and analysis provided to allow replication by others?
Yes
If applicable, is the statistical analysis and its interpretation appropriate?
Yes
Are all the source data underlying the results available to ensure full reproducibility?
Yes
Are the conclusions drawn adequately supported by the results?
Yes
 No competing interests were disclosed.Competing Interests:
Reviewer Expertise: Pediatric oncologist (physician-scientist); translational research focusing on genetic
analyses of neuroblastoma and other high risk pediatric cancers
I confirm that I have read this submission and believe that I have an appropriate level of
expertise to confirm that it is of an acceptable scientific standard.
 02 July 2019Reviewer Report
https://doi.org/10.5256/f1000research.19917.r49683
© 2019 Gray J. This is an open access peer review report distributed under the terms of the Creative Commons
, which permits unrestricted use, distribution, and reproduction in any medium, provided the originalAttribution Licence
work is properly cited.
 Juliet C. Gray
Antibody and Vaccine Group, Centre for Cancer Immunology, Faculty of Medicine, Department of
Paediatric Oncology, University of Southampton, Southampton, UK
Neuroblastoma is a rare paediatric tumour which accounts for a disproportionately high number of
paediatric cancer deaths. Fresh tissue samples are usually small and scarce, and established cell lines
are likely to poorly represent the heterogenous nature of the disease. This paper describes a simple
methodology for establishing neurosphere cultures from small samples of fresh biopsy tissue, with a
relatively high success rate. This is a potentially very useful technique for extending the use of limited
primary tissue samples to maximal benefit. Of note, success was even achieved with fluid  from around
surgical/biopsy samples, rather than solid tissue samples, which is potentially very useful when sample
size is limited.
The article is clearly written and will be of interest to those working in the field.
Is the work clearly and accurately presented and does it cite the current literature?
Yes
Is the study design appropriate and is the work technically sound?
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 Is the study design appropriate and is the work technically sound?
Yes
Are sufficient details of methods and analysis provided to allow replication by others?
Yes
If applicable, is the statistical analysis and its interpretation appropriate?
Yes
Are all the source data underlying the results available to ensure full reproducibility?
Yes
Are the conclusions drawn adequately supported by the results?
Yes
 No competing interests were disclosed.Competing Interests:
Reviewer Expertise: Neuroblastoma
I confirm that I have read this submission and believe that I have an appropriate level of
expertise to confirm that it is of an acceptable scientific standard.
 01 July 2019Reviewer Report
https://doi.org/10.5256/f1000research.19917.r49685
© 2019 Trahair T. This is an open access peer review report distributed under the terms of the Creative Commons
, which permits unrestricted use, distribution, and reproduction in any medium, provided the originalAttribution Licence
work is properly cited.
 Toby Trahair
Sydney Children's Hospital, Randwick, NSW, Australia
This is a straightforward technical report on direct culture of neuroblastoma samples from consecutive
cases treated at Great Ormond Street.
The research team has taken a logical approach to establishing an easy method to establish
patient-derived neurospheres. Tumour samples were derived from a number of sources (open biopsy,
needle biopsy & from transport fluid). The overall success rate (37 cultures from 67 samples) confirms
that this approach is feasible.
The characterisation of the resulting neurosphere cultures has been limited, but expression of both CD56
and GD2 suggests that the cultures really are neuroblastic tumours.
The significance of this work really lies in the downstream application of patient-derived cultures. There
are a number of unanswered questions, specifically how representative the neurosphere cultures are of
the donor tumour, whether there is any correlation between the capacity to establish a culture and patient
outcome, whether the neurosphere models can be propagated as xenografts, and if it is possible to derive
neurosphere cultures from each genetic/genomic subtype of neuroblastoma (e.g. MYCN amplified, TERT
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 neurosphere cultures from each genetic/genomic subtype of neuroblastoma (e.g. MYCN amplified, TERT
rearranged, ATRX deleted, etc.).
Overall, with an increasing focus on personalisation of therapy, whilst a simple piece of work, I believe it is
a valuable contribution to the field and will be helpful for other groups engaged in such work.
Is the work clearly and accurately presented and does it cite the current literature?
Yes
Is the study design appropriate and is the work technically sound?
Yes
Are sufficient details of methods and analysis provided to allow replication by others?
Yes
If applicable, is the statistical analysis and its interpretation appropriate?
Yes
Are all the source data underlying the results available to ensure full reproducibility?
Yes
Are the conclusions drawn adequately supported by the results?
Yes
 No competing interests were disclosed.Competing Interests:
Reviewer Expertise: Paediatric Haematologist & Oncologist, translational research in neuroblastoma &
personalised medicine
I confirm that I have read this submission and believe that I have an appropriate level of
expertise to confirm that it is of an acceptable scientific standard.
 01 July 2019Reviewer Report
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© 2019 Murphy D. This is an open access peer review report distributed under the terms of the Creative Commons
, which permits unrestricted use, distribution, and reproduction in any medium, provided the originalAttribution Licence
work is properly cited.
   Dermot Murphy
Schiehallion Unit, Royal Hospital for Sick Children, Glasgow, UK
The article is scientifically sound. My only criticism is stylistic. I think the sentences are too long and the
punctuation could be better. The text is clunky.
For example:
“The disease is strikingly heterogeneous with a range of clinical phenotypes, from spontaneous
regression, including in cases with metastases, to aggressive disease with marked resistance to
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 regression, including in cases with metastases, to aggressive disease with marked resistance to
radiotherapy and chemotherapy. New approaches to therapies supported by the availability of
suitable tumor models that more closely resemble the human disease are essential for improving
outcomes for this disease.”
 
Edit to:
Neuroblastoma is strikingly heterogeneous. Clinical phenotypes range from spontaneous
regression to aggressive disease characterised by marked resistance to radio and chemotherapy.
New therapeutic approaches, supported by tumor models more closely resembling human
disease, are essential for improving outcomes in children.
There are many more examples in the subsequent manuscript. Tight editing would vastly improve
readability.
Is the work clearly and accurately presented and does it cite the current literature?
Yes
Is the study design appropriate and is the work technically sound?
Yes
Are sufficient details of methods and analysis provided to allow replication by others?
Yes
If applicable, is the statistical analysis and its interpretation appropriate?
Yes
Are all the source data underlying the results available to ensure full reproducibility?
Yes
Are the conclusions drawn adequately supported by the results?
Yes
 No competing interests were disclosed.Competing Interests:
Reviewer Expertise: Neuroblastoma and children's cancer in general. Palliative care, statistics.
I confirm that I have read this submission and believe that I have an appropriate level of
expertise to confirm that it is of an acceptable scientific standard.
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